elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53693522-8126B69B-B4F0-4E8B-B31E-66F2DD0C3788
Q53693522-8126B69B-B4F0-4E8B-B31E-66F2DD0C3788
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53693522-8126B69B-B4F0-4E8B-B31E-66F2DD0C3788
MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.
P2860
Q53693522-8126B69B-B4F0-4E8B-B31E-66F2DD0C3788
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53693522-8126B69B-B4F0-4E8B-B31E-66F2DD0C3788
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6910b03525149c4d710102d3c112f98e2bd11331
P2860
Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer.